title: US approves "new class" of diabetes drug, under review in Canada.
authors.forename: Hanna
authors.initials: H
authors.lastname: Lange-Chenier
mesh_terms: D002170:Canada; D000068896:Canagliflozin; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017277:Drug Approval; D005960:Glucosides / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D013876:Thiophenes / Q000627:therapeutic use*; D014481:United States
chemical_list: D005960:Glucosides; D007004:Hypoglycemic Agents; D013876:Thiophenes; D000068896:Canagliflozin